Clinical Pharmacology Clinical Research Clinical Trials 
Alta Sciences
JANUARY 23, 2024
“James’ proven leadership skills, and deep knowledge of all phases of clinical research, will be invaluable in delivering expert guidance for our clients along their early-phase clinical journey,” said Ingrid Holmes, Vice President, Clinical Operations, Altasciences.
Drug Target Review
MAY 7, 2024
AI holds the potential to revolutionise different aspects of healthcare, particularly in the realm of clinical trials. By leveraging AI technologies, we could create a more accessible and equitable approach to clinical trials, breaking down barriers to participation and ensuring diverse representation among participants.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Alta Sciences
DECEMBER 14, 2023
Adherence to harmonized pharmacy-specific SOPs based on cGMP principles at our three clinical pharmacology units. Clinical Supply Manufacturing Integration with our manufacturing team, ensuring flexibility and adaptability to meet the evolving needs of your studies throughout your drug development program or study.
The Premier Consulting Blog
JUNE 18, 2023
One exciting application of these technologies is the use of in silico trials in the development of novel therapies for rare diseases. However, with rare diseases there may be no available treatments that could serve as SoC or active control in a clinical trial and assigning patients to placebo may be unethical.
Alta Sciences
AUGUST 28, 2023
We wish the team at Ischemix continued success on the next Phase of clinical research.” Julie-Ann Cabana Altasciences +1 514 601-9763 jcabana@altasciences.com Date of publication August 30, 2023 Weight 1 Tags Clinical Trials Altasciences helps sponsors get better drugs to the people who need them, faster.
The Anticancer Fund
JUNE 7, 2022
This is another study that is strongly supportive of replication and further development, including clinical trial development. Gauthier Bouche & Pan Pantziarka Gauthier Bouche (MD) is Director of Clinical Research at the Anticancer Fund. You will automatically receive updates on this topic in your mailbox.
Agency IQ
OCTOBER 27, 2023
12/29/2023 FDORA, Section 3602 Clinical Trials Modernization : FDA is directed to require the submission of a “diversity action plan” for all Phase 3 clinical trials of new drugs. FDA is directed to issue new draft guidance or update existing guidance regarding Diversity Action Plans for clinical studies.
Expert insights. Personalized for you.
40 
Let's personalize your content